Get Premium to unlock powerful stock data
Accelerate Diagnostics Inc logo

Accelerate Diagnostics Inc

$ 0.61 -0.0803 (-11.63%) 09:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 42.49M
Enterprise V:
$ 95.59M
Volume:
593.10K
Avg Vol (2M):
565.22K
Also Trade In:
Volume:
593.10K
Market Cap $:
42.49M
PE Ratio:
At Loss
Avg Vol (2-Month):
565.22K
Enterprise Value $:
95.59M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Accelerate Diagnostics Inc
NAICS : 325413 SIC : 5047
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.
Name Current Vs Industry Vs History
Cash-To-Debt 0.57
Equity-to-Asset -0.42
Debt-to-Equity -3.17
Debt-to-EBITDA -1.87
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.74
Distress
Grey
Safe
Beneish M-Score -11.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 9.91
9-Day RSI 14.96
14-Day RSI 19.14
6-1 Month Momentum % -83.17
12-1 Month Momentum % -85.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.56
Quick Ratio 9.83
Cash Ratio 9.16
Days Inventory 260.31
Days Sales Outstanding 63.38
Days Payable 56.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.6
Name Current Vs Industry Vs History
Gross Margin % -3.24
Operating Margin % -607.43
Net Margin % -659.55
ROA % -87.45
ROIC % -396.76
ROC (Joel Greenblatt) % -395.02
ROCE % -76.46

Financials (Next Earnings Date:2022-05-16)

AXDX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AXDX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 11.781
EPS (TTM) ($) -1.27
Beta 1.09
Volatility % 58.02
14-Day RSI 19.14
14-Day ATR ($) 0.108667
20-Day SMA ($) 0.88094
12-1 Month Momentum % -85.29
52-Week Range ($) 0.605 - 9.36
Shares Outstanding (Mil) 69.66

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Accelerate Diagnostics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More